Christy and Jim Donovan Fund for Prostate Cancer Research at DFCI

After his college roommate and fraternity brother’s life was cut short by cancer, Jim Donovan vowed to help other patients battle their diseases.
Today, the Institute trustee has taken aim at prostate cancer with a gift of $100,000 to Dana-Farber Cancer Institute.

“Prostate cancer affects such a broad group of people yet doesn’t always
receive the attention it warrants,” said Donovan, a partner at Goldman, Sachs &
Co. “I felt something needed to be done.”
This gift will establish the Christy and Jim Donovan Fund for Prostate Cancer
Research at DFCI, supporting research by Philip Kantoff, MD, chief clinical
research officer and director of the Lank Center for Genitourinary Oncology.
“Many questions still remain with regard to prostate cancer, including which
specific treatments, such as surgery, chemotherapy, or hormonal therapy, are
optimal for individual patients,” said Kantoff. “With our studies, we hope to
better forecast which patients will respond best to such treatments.”
Donovan’s gift also provides critical support to Mission Possible: The Dana-
Farber Campaign to Conquer Cancer. Publicly launched in January 2007, the $1 billion
campaign builds on the Institute’s time-tested, translational research model of
ushering promising findings from the laboratory quickly into the clinic to benefit patients—creating a catalyst for preventing, controlling, and conquering cancer.